Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Eileen Harder, M.D.

Title
Institution
Department
Address
Phone

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Minhas J, Nardelli P, Hassan SM, Al-Naamani N, Harder E, Ash S, Sánchez-Ferrero GV, Mason S, Hunsaker AR, Piazza G, Goldhaber SZ, Waxman AB, Kawut SM, Estépar RSJ, Washko GR, Rahaghi FN. Loss of Pulmonary Vascular Volume as a Predictor of Right Ventricular Dysfunction and Mortality in Acute Pulmonary Embolism. Circ Cardiovasc Imaging. 2021 09; 14(9):e012347. PMID: 34544259; PMCID: PMC8462092.
    Citations: 1     Fields:    Translation:Humans
  2. Rahaghi FN, Nardelli P, Harder E, Singh I, Sánchez-Ferrero GV, Ross JC, San José Estépar R, Ash SY, Hunsaker AR, Maron BA, Leopold JA, Waxman AB, San José Estépar R, Washko GR. Quantification of Arterial and Venous Morphologic Markers in Pulmonary Arterial Hypertension Using CT Imaging. Chest. 2021 12; 160(6):2220-2231. PMID: 34270966; PMCID: PMC8692106.
    Citations: 2     Fields:    Translation:Humans
  3. Harder EM, Vanderpool R, Rahaghi FN. Advanced Imaging in Pulmonary Vascular Disease. Clin Chest Med. 2021 03; 42(1):101-112. PMID: 33541604.
    Citations:    Fields:    Translation:Humans
  4. Harder EM, Waxman AB. Clinical trials in group 3 pulmonary hypertension. Curr Opin Pulm Med. 2020 09; 26(5):391-396. PMID: 32657833.
    Citations: 2     Fields:    Translation:Humans
  5. Harder EM, Small AM, Fares WH. Primary cardiac hospitalizations in pulmonary arterial hypertension: Trends and outcomes from 2001 to 2014. Respir Med. 2020 01; 161:105850. PMID: 32056724.
    Citations: 4     Fields:    Translation:Humans
  6. Harder EM, Fares WH. Hospitalizations with hereditary hemorrhagic telangiectasia and pulmonary hypertension in the United States from 2000 to 2014. Respir Med. 2019 02; 147:26-30. PMID: 30704695.
    Citations: 3     Fields:    Translation:Humans
  7. Harder EM, Desai O, Marshall PS. Clinical Probability Tools for Deep Venous Thrombosis, Pulmonary Embolism, and Bleeding. Clin Chest Med. 2018 09; 39(3):473-482. PMID: 30122172.
    Citations: 1     Fields:    Translation:Humans
  8. Harder EM, Chen ZJ, Park HS, Mancini BR, Decker RH. Dose-Volume Predictors of Esophagitis After Thoracic Stereotactic Body Radiation Therapy. Am J Clin Oncol. 2017 Oct; 40(5):477-482. PMID: 26017483.
    Citations: 1     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  9. Stahl JM, Ross R, Harder EM, Mancini BR, Soulos PR, Finkelstein SE, Shafman TD, Dosoretz AP, Evans SB, Husain ZA, Yu JB, Gross CP, Decker RH. The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016 12 01; 96(5):1011-1020. PMID: 27869080.
    Citations: 11     Fields:    Translation:Humans
  10. Mancini BR, Park HS, Harder EM, Rutter CE, Corso CD, Decker RH, Husain ZA. Elderly patients undergoing SBRT for inoperable early-stage NSCLC achieve similar outcomes to younger patients. Lung Cancer. 2016 07; 97:22-7. PMID: 27237023.
    Citations: 8     Fields:    Translation:Humans
  11. Harder EM, Park HS, Chen ZJ, Decker RH. Pulmonary dose-volume predictors of radiation pneumonitis following stereotactic body radiation therapy. Pract Radiat Oncol. 2016 Nov - Dec; 6(6):e353-e359. PMID: 27156424.
    Citations: 9     Fields:    Translation:Humans
  12. Harder EM, Park HS, Nath SK, Mancini BR, Decker RH. Angiotensin-converting enzyme inhibitors decrease the risk of radiation pneumonitis after stereotactic body radiation therapy. Pract Radiat Oncol. 2015 Nov-Dec; 5(6):e643-9. PMID: 26412341.
    Citations: 15     Fields:    Translation:Humans
  13. Park HS, Harder EM, Mancini BR, Decker RH. Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non-Small-Cell Lung Cancer. J Thorac Oncol. 2015 May; 10(5):832-837. PMID: 25634007.
    Citations: 24     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Harder's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (82)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.